journal article·2022-12-31Open access

Formulation and evaluation of niosomes-based chlorpheniramine gel for the treatment of mild to moderate skin allergy

Urooj Afreen, Khairi Mustafa Fahelelbom, Syed Nisar Hussain Shah, Akram Ashames, Uzma Almas, Shujaat Ali Khan, Muhammad Arfat Yameen, Naveed Nisar, Muhammad Hassham Hassan Bin Asad, Ghulam Murtaza

Abstract

Purpose of present study was to develop eight formulations of chlorpheniramine (CPM) niosomes according to 23 factorial design, characterise on the basis of various evaluation tests, i.e. in vitro drug release, SEM, FTIR, TGA and release kinetics, optimise the eight formulation on the basis in vitro drug release data, formulate gel of optimised dispersion, and to perform in vivo and histopathological study using gel of optimised dispersion on rabbits. Here, N3 having low level of cholesterol and span-80 but high level of span-60(0.1:0.2:0.05) was selected as optimised dispersion of niosomes that showed highest drug release i.e. 88.25% at pH 6 over 24 h of study and followed Korsmeyers-Peppas release kinetics with Fickian diffusion mechanism. After application of statistic by Analysis of variance (ANOVA) with 3D surface plots construction, gel of optimised dispersion of CPM niosomes was formulated, and evaluated by tests for i.e. viscosity, Spreadability, Extrudibility, drug content, drug entrapment, stability, SEM, FTIR, TGA, in vitro drug release, in vivo drug release following first order kinetics and histopathological study. Niosomal gel of CPM ensured successful development using suitable combination of non-ionic surfactants, and effective loading of drug for targeted delivery of drug.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Contact Dermatitis and Allergies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, BahauddinZakariya University, Multan, Pakistan

Department of Pharmaceutical Sciences, College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates

Medical and Bio-allied Health Sciences Research Centre, Ajman University, Ajman, UAE

Department of Pharmaceutical Sciences, Ajman University, Ajman, UAE

Department of Dermatology, Bahawal Victoria Hospital, Bahawalpur, Pakistan

Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan

Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan

References (70)

Show source-provided references
1. Gyati SA, Abhay A, Davinder S, et al. Etodolac containing topical niosomal gel: Formulation development and evaluation. J Drug Deliv. 2016;2016:9324567.10.1155/2016/9324567 ↗
2. 10.1208/aapsj07012010.1208/aapsj070120 ↗
3. 10.1023/A:101606040343810.1023/A:1016060403438 ↗
4. 10.1002/jps.260079071110.1002/jps.2600790711 ↗
5. 10.1046/j.0909-752x.2001.10311.x10.1046/j.0909-752x.2001.10311.x ↗
6. Misra AN. · 1997 · 8 · 100
7. 10.2174/156720105277291510.2174/1567201052772915 ↗
8. 10.4314/tjpr.v14i2.210.4314/tjpr.v14i2.2 ↗
9. 10.1016/S0378-5173(00)00374-410.1016/S0378-5173(00)00374-4 ↗
10. 10.1016/S0378-5173(99)00338-510.1016/S0378-5173(99)00338-5 ↗
11. 10.3109/0363904930906298910.3109/03639049309062989 ↗
12. 10.1038/sj.bjp.070644010.1038/sj.bjp.0706440 ↗
13. 10.1016/S0928-0987(01)00167-110.1016/S0928-0987(01)00167-1 ↗
14. 10.1081/DDC-10010226610.1081/DDC-100102266 ↗
15. Balata GF · JIPBS · 2017 · 4 · 49
16. 10.1111/j.1529-8019.2012.01464.x10.1111/j.1529-8019.2012.01464.x ↗
17. Korting HC · HandbExpPharmacol · 2010 · 197 · 435
18. 10.1517/1742524090307102910.1517/17425240903071029 ↗
19. 10.2174/138920101666615020610144310.2174/1389201016666150206101443 ↗
20. 10.3109/10837450.2014.92691910.3109/10837450.2014.926919 ↗
21. 10.1080/08982104.2016.122489710.1080/08982104.2016.1224897 ↗
22. Varghese V · Indian Drugs · 2004 · 41 · 101
23. VardeNeha M · IJRPB · 2013 · 1 · 180
24. 10.5101/nbe.v9i3.p242-24810.5101/nbe.v9i3.p242-248 ↗
25. 10.3109/03639045.2015.105483210.3109/03639045.2015.1054832 ↗
26. Javed H · AAPSPharmSci’Tech · 2018 · 19 · 1730
27. Jaiswal PH · IJPPR Human · 2016 · 6 · 585
28. Bhattacharya SA · Med Clin Res · 2017 · 2 · 1
29. Riaz R · Lat Am J Pharm · 2017 · 36 · 2028
30. 10.1016/S0142-9612(03)00419-810.1016/S0142-9612(03)00419-8 ↗
31. 10.3109/10717544.2013.85527710.3109/10717544.2013.855277 ↗
32. Fathalla D · IJPSR · 2014 · 1 · 105
33. 10.5138/ijdd.2010.0975.0215.0201410.5138/ijdd.2010.0975.0215.02014 ↗
34. 10.1016/j.ijpharm.2010.08.00610.1016/j.ijpharm.2010.08.006 ↗
35. 10.1590/S1984-8250201300030000410.1590/S1984-82502013000300004 ↗
36. 10.1080/1071754080195263910.1080/10717540801952639 ↗
37. 10.1111/j.1439-0442.1998.tb00815.x10.1111/j.1439-0442.1998.tb00815.x ↗
38. Shinde UA · J Pharm · 2014 · 2014 · 1
39. 10.4103/0973-8398.6397810.4103/0973-8398.63978 ↗
40. 10.1007/s10856-009-3864-410.1007/s10856-009-3864-4 ↗
41. Khan MI · Brazilian JPS · 2015 · 51 · 608
42. 10.3109/0265204950901029210.3109/02652049509010292 ↗
43. 10.1016/j.ijpharm.2009.04.02010.1016/j.ijpharm.2009.04.020 ↗
44. 10.1016/j.chemphyslip.2006.08.00510.1016/j.chemphyslip.2006.08.005 ↗
45. 10.1016/0009-3084(90)90008-F10.1016/0009-3084(90)90008-F ↗
46. 10.1023/A:101621051513410.1023/A:1016210515134 ↗
47. Jigar V · Int J Pharm Pharm Sci · 2011 · 3 · 123
48. 10.1016/0378-5173(94)90228-310.1016/0378-5173(94)90228-3 ↗
49. Singh CH · Pharmacophore · 2011 · 2 · 168
50. Asthana GS · JDD · 2016 · 16 · 8
51. 10.1016/S0378-5173(98)00169-010.1016/S0378-5173(98)00169-0 ↗
52. Siddiqui N · Int J Pharm Sci · 2010 · 4 · 87
53. 10.9734/BJPR/2016/2698510.9734/BJPR/2016/26985 ↗
54. Swami H · WJPR · 2015 · 4 · 2312
55. Kamboj S · IJMH · 2013 · 12 · 1
56. Boushra M · DDT · 2010 · 4 · 33
57. Garg A · Pharm Tech · 2002 · 9 · 89
58. Bhaskaran S · Ind. J. Pharm. Sci · 2002 · 1 · 63
59. Nagalakshmi S · J Pharm Sci Res · 2016 · 8 · 1271
60. Salih OS · IJPPS · 2013 · 5 · 525
61. Van-Abbe NJ · J SocCosmet Chem · 1975 · 26 · 173
62. 10.1248/cpb.32.372010.1248/cpb.32.3720 ↗
63. 10.1007/s00436-013-3422-310.1007/s00436-013-3422-3 ↗
64. 10.1084/jem.97.2.25710.1084/jem.97.2.257 ↗
65. Baroody FM. · Clin Allergy Immunol · 2007 · 19 · 110.1027/0838-1925.19.1.1 ↗
66. 10.1155/MI.2005.22810.1155/MI.2005.228 ↗
67. Gartner LP · 2006 · 2006
68. Farshid AA · Vet Res Forum · 2011 · 2 · 31
69. 10.1007/BF0225294310.1007/BF02252943 ↗
70. 10.1016/S0014-827X(03)00080-610.1016/S0014-827X(03)00080-6 ↗